161 related articles for article (PubMed ID: 34520678)
1. Collaboration in a time of crisis: Adapting a telementoring ECHO for addiction leaders during COVID-19.
Englander H; Patten A; Gregg J
Subst Abus; 2022; 43(1):547-550. PubMed ID: 34520678
[TBL] [Abstract][Full Text] [Related]
2. Spreading Addictions Care Across Oregon's Rural and Community Hospitals: Mixed-Methods Evaluation of an Interprofessional Telementoring ECHO Program.
Englander H; Patten A; Lockard R; Muller M; Gregg J
J Gen Intern Med; 2021 Jan; 36(1):100-107. PubMed ID: 32885371
[TBL] [Abstract][Full Text] [Related]
3. Using Project Extension for Community Healthcare Outcomes to Enhance Substance Use Disorder Care in Primary Care: Mixed Methods Study.
Koester M; Motz R; Porto A; Reyes Nieves N; Ashley K
JMIR Med Educ; 2024 Apr; 10():e48135. PubMed ID: 38557477
[TBL] [Abstract][Full Text] [Related]
4. "The post-COVID era": challenges in the treatment of substance use disorder (SUD) after the pandemic.
López-Pelayo H; Aubin HJ; Drummond C; Dom G; Pascual F; Rehm J; Saitz R; Scafato E; Gual A
BMC Med; 2020 Jul; 18(1):241. PubMed ID: 32731868
[TBL] [Abstract][Full Text] [Related]
5. COVID 19-impact on substance use treatment utilization and provision in South Africa.
Harker N; Johnson K; Erasmus J; Myers B
Subst Abuse Treat Prev Policy; 2022 Mar; 17(1):15. PubMed ID: 35241095
[TBL] [Abstract][Full Text] [Related]
6. Persons with Substance Abuse Disorders and Other Addictions: Coping with the COVID-19 Pandemic.
Fabelo-Roche JR; Iglesias-Moré S; Gómez-García AM
MEDICC Rev; 2021 Apr; 23(2):55. PubMed ID: 33974609
[TBL] [Abstract][Full Text] [Related]
7. Substance Use Disorder Treatment Programs during a Health Crisis: Response to the COVID-19 Pandemic and Future Implications.
Baloh J; Charton H; Curran GM
Subst Use Misuse; 2023; 58(14):1855-1865. PubMed ID: 37722809
[No Abstract] [Full Text] [Related]
8. A Global Pandemic and Substance Use Disorder: Healthcare Professionals' Viewpoints on the Merging of Two Crises.
Shreffler J; Shreffler M; Murfree JR; Huecker M
Subst Use Misuse; 2021; 56(10):1476-1482. PubMed ID: 34130597
[TBL] [Abstract][Full Text] [Related]
9. "How can I hug someone now [over the phone]?": Impacts of COVID-19 on peer recovery specialists and clients in substance use treatment.
Anvari MS; Seitz-Brown CJ; Spencer J; Mulheron M; Abdelwahab S; Borba CPC; Magidson JF; Felton JW
J Subst Abuse Treat; 2021 Dec; 131():108649. PubMed ID: 34716038
[TBL] [Abstract][Full Text] [Related]
10. Leveraging Project ECHO to Implement a Suite of Substance Use Learning Communities for Statewide Impact.
Lindsey AC; Deem-Bolton C; Finley E; Potter JS; Lanham H; Fleming S
Subst Use Addctn J; 2024 May; ():29767342241252296. PubMed ID: 38756013
[TBL] [Abstract][Full Text] [Related]
11. Leading through the first wave of COVID: a Canadian action research study.
Hartney E; Melis E; Taylor D; Dickson G; Tholl B; Grimes K; Chan MK; Van Aerde J; Horsley T
Leadersh Health Serv (Bradf Engl); 2021 Dec; ahead-of-print(ahead-of-print):. PubMed ID: 34898142
[TBL] [Abstract][Full Text] [Related]
12. Treatment Disruption and Childcare Responsibility as Risk Factors for Drug and Alcohol Use in Persons in Treatment for Substance Use Disorders During the COVID-19 Crisis.
Huhn AS; Strain EC; Jardot J; Turner G; Bergeria CL; Nayak S; Dunn KE
J Addict Med; 2022 Jan-Feb 01; 16(1):e8-e15. PubMed ID: 33560698
[TBL] [Abstract][Full Text] [Related]
13. Policies to Improve Substance Use Disorder Treatment With Telehealth During the COVID-19 Pandemic and Beyond.
Drake C; Yu J; Lurie N; Kraemer K; Polsky D; Chaiyachati KH
J Addict Med; 2020; 14(5):e139-e141. PubMed ID: 32826619
[TBL] [Abstract][Full Text] [Related]
14. Using qualitative, community-based input to steer post-coronavirus disease 2019 pharmacy practice in substance use.
Kosobuski L; Hawn A; France K; Chen N; LaPlante C; Palombi L
J Am Pharm Assoc (2003); 2022; 62(5):1555-1563.e2. PubMed ID: 35428578
[TBL] [Abstract][Full Text] [Related]
15. Changes in Admissions to Specialty Addiction Treatment Facilities in California During the COVID-19 Pandemic.
Mark TL; Gibbons B; Barnosky A; Padwa H; Joshi V
JAMA Netw Open; 2021 Jul; 4(7):e2117029. PubMed ID: 34259852
[TBL] [Abstract][Full Text] [Related]
16. Impacts of COVID-19 on residential treatment programs for substance use disorder.
Pagano A; Hosakote S; Kapiteni K; Straus ER; Wong J; Guydish JR
J Subst Abuse Treat; 2021 Apr; 123():108255. PubMed ID: 33375986
[TBL] [Abstract][Full Text] [Related]
17. Clinicians' Core Needs in a Pandemic: Qualitative Findings From the Chat Box in a Statewide COVID-19 ECHO Program.
Steeves-Reece AL; Elder NC; Broadwell KD; Stock RD
Ann Fam Med; 2022; 20(1):51-56. PubMed ID: 35074768
[TBL] [Abstract][Full Text] [Related]
18. Addictive behaviors and craving during the COVID-19 pandemic of people who have recovered from substance use disorder.
Bonny-Noach H; Gold D
J Addict Dis; 2021; 39(2):257-264. PubMed ID: 33305702
[TBL] [Abstract][Full Text] [Related]
19. How emergency department visits for substance use disorders have evolved during the early COVID-19 pandemic.
Pines JM; Zocchi MS; Black BS; Carlson JN; Celedon P; Moghtaderi A; Venkat A
J Subst Abuse Treat; 2021 Oct; 129():108391. PubMed ID: 33994360
[TBL] [Abstract][Full Text] [Related]
20. Innovative COVID-19 Programs to Rapidly Serve New Mexico : Project ECHO.
Katzman JG; Tomedi LE; Thornton K; Menking P; Stanton M; Sosa N; Harkins M; Katzman N; Liu J; Archer GRD; Arora S
Public Health Rep; 2021; 136(1):39-46. PubMed ID: 33216679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
